Kaken Pharmaceutical Co (TSE:4521) Other Operating Expense : 円18,769 Mil (TTM As of Dec. 2024)

View and export this data going back to 1961. Start your Free Trial

What is Kaken Pharmaceutical Co Other Operating Expense?

Kaken Pharmaceutical Co's Other Operating Expense for the three months ended in Dec. 2024 was 円4,664 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was 円18,769 Mil.

Kaken Pharmaceutical Co's quarterly Other Operating Expense declined from Jun. 2024 (円4,302 Mil) to Sep. 2024 (円4,246 Mil) but then increased from Sep. 2024 (円4,246 Mil) to Dec. 2024 (円4,664 Mil).

Kaken Pharmaceutical Co's annual Other Operating Expense increased from Mar. 2023 (円15,764 Mil) to Mar. 2024 (円16,479 Mil) and increased from Mar. 2024 (円16,479 Mil) to Mar. 2025 (円18,769 Mil).

Kaken Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Kaken Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaken Pharmaceutical Co Other Operating Expense Chart

Kaken Pharmaceutical Co Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Other Operating Expense

Get a 7-Day Free Trial

16,379.00

16,088.00

15,764.00

16,479.00

18,769.00

Kaken Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															3,997.00	4,302.00	4,246.00	4,664.00	5,557.00

Kaken Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円18,769 Mil.

Kaken Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Kaken Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Kaken Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaken Pharmaceutical Co Ltd (TSE:4521) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

KKPCF:USA

Address

28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650

Website

http://www.kaken.co.jp

Kaken Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kaken Pharmaceutical Co Headlines

No Headlines